佐力药业三十而立，乌灵新品牌发布剑指院外广阔天地

Core Viewpoint - Zhaoli Pharmaceutical is focusing on bridging the gap between hospital and consumer markets, aiming to reconstruct the value chain in the C-end consumer market and achieve a revenue target of 10 billion yuan [1] Strategic Upgrade and Brand Development - Zhaoli Pharmaceutical plans to leverage policies and partnerships to strengthen its core products and operational capabilities, establishing the Wuling brand as a super brand in the market [2] - The company has historically relied on the hospital market for growth, with its core product, Wuling Capsule, being a major item in the traditional Chinese medicine sector [2][3] - The launch of the Wuling brand's "super symbol" marks an upgrade in the company's strategy towards the C-end market, aiming to enhance brand recognition among the general public [2] C-end Market Strategy - The core of the Wuling brand strategy is to effectively convert product strength and brand recognition from hospitals to direct consumer influence [3] - Zhaoli has established an independent OTC division and is enhancing partnerships with major pharmacy chains while expanding into e-commerce and O2O retail channels [3] - The company has seen positive results in certain markets, with membership management leading to a product repurchase rate increase from 10% to 25% [3] Opportunities in Sleep Health - Zhaoli's C-end strategy is built on the clinical efficacy of its products, particularly the Wuling Capsule, which has shown benefits in improving sleep and cognitive function [4] - The company recognizes the significant market opportunity in addressing sleep disorders, with nearly 48.5% of adults in China experiencing sleep issues [4] - Currently, C-end revenue accounts for only about 10% of total revenue, with a goal to increase this to 30% [4] Multi-layered C-end Marketing Strategy - The company plans to implement a comprehensive C-end marketing strategy in 2026, focusing on building brand recognition through online media and community education initiatives [5] - Collaborations with pharmacy chains will include creating dedicated "Wuling Sleep Zones" to enhance sales capabilities [5] Building a New Health Consumption Ecosystem - Zhaoli's push into the C-end market is a critical step in reshaping its brand and business ecosystem, with the Wuling brand's super symbol serving as a foundation for future growth [6] - The company aims to develop a comprehensive "Wuling + X" ecosystem, with ongoing research and development in various health-related areas [6] - A diverse growth matrix is emerging, with continued penetration in hospital markets and rapid expansion in retail [6] Conclusion - Zhaoli Pharmaceutical is at a pivotal moment, balancing its established hospital market presence with ambitious plans for consumer market expansion, reflecting broader trends in the modernization of traditional Chinese medicine under the Healthy China strategy [7]